NCT01183273

Brief Summary

Background Laparoscopy is the preferred surgical approach for a number of different diseases as it allows for diagnosis and treatment in the setting of a safe and feasible method offering enhanced cosmesis. The natural evolution of laparoscopy is micro-laparoscopy which utilizes smaller instruments and optics. Technological advancements have enabled miniaturization of the surgical equipment without compromising diagnostic or operative capabilities. Dr. Keith Zuccala is currently performing micro-laparoscopic gastric bypass with an identical safety profile as traditional laparoscopy (NSQIP data comparison between Dr. Laura Choi and Dr. Keith Zuccala). The current trend in laparoscopy is to minimize incisions and their size to decrease trauma to the abdominal wall. Study Design Both methods have never been compared in a prospective randomized trial to address the following questions.

  1. 1.Is there a difference in outcome?
  2. 2.Is there a decrease in postoperative pain?
  3. 3.Does it decrease time off from work?
  4. 4.Does micro-laparoscopy increase OR time?
  5. 5.What is the effect on cost of micro-laparoscopy? Patients will be randomized to one or the other method, disclosing that to the investigators best knowledge both methods are equally safe and that Dr. Zuccala has performed several hundred cases using both methods.
  6. 6.NSQIP data to assess outcome
  7. 7.Postoperative usage of pain medication while in the hospital
  8. 8.Time off from work
  9. 9.OR time
  10. 10.Direct cost of procedure as it relates to material used

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for not_applicable obesity

Timeline
Completed

Started Mar 2010

Longer than P75 for not_applicable obesity

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2010

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

August 9, 2010

Completed
8 days until next milestone

First Posted

Study publicly available on registry

August 17, 2010

Completed
3.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2014

Completed
Last Updated

August 22, 2014

Status Verified

August 1, 2014

Enrollment Period

4.3 years

First QC Date

August 9, 2010

Last Update Submit

August 21, 2014

Conditions

Outcome Measures

Primary Outcomes (1)

  • Safety of micro-laparoscopic versus laparoscopic gastric bypass

    2 years

Secondary Outcomes (4)

  • Postoperative pain

    30 days

  • Time off from work

    30 days

  • Operating Cost

    The time of surgery is collected following patient discharge approximately 4 to 5 days

  • Time of Surgery

    The time of surgery is collected following patient discharge approximately 4 to 5 days.

Study Arms (2)

Micro-laparoscopic bypass

ACTIVE COMPARATOR
Procedure: Microlaparoscopic gastric bypass

Laparoscopic gastric bypass

ACTIVE COMPARATOR
Procedure: Laparoscopic Surgery

Interventions

microlaparoscopic gastric bypass will be performed using standard of care procedure.

Micro-laparoscopic bypass

laparoscopic gastric bypass will be performed using standard of care procedure.

Laparoscopic gastric bypass

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • A body mass index (BMI) ≥ 40 with or without co-morbid conditions\*
  • A BMI ≥ 35 with co-morbid conditions\*
  • Permanent lifestyle changes including exercise
  • No significant, untreated psychiatric illnesses
  • Age ≥ 18 years
  • Sufficient ability and cognition to understand surgery, potential complications and subsequent associated changes
  • Willingness to participate in treatment and long-term follow-up
  • Proof of failed attempts at non-surgical weight reduction
  • Acceptable medical/operative risks \* Co-morbid solutions include: hypertension, diabetes mellitus, cardiac disease, hypercholesterolemia/hyperlipidemia, sleep apnea, asthma, hypoventilation syndrome of obesity, degenerative joint disease, gastro-esophageal reflux disease, venous stasis ulcers, depression, menstrual irregularities/infertility, polycystic ovary syndrome, fungal skin infections.

You may not qualify if:

  • The need to convert from laparoscopic roux-n-y to an open abdominal procedure.
  • Patients with congestive heart failure or other serious illness which would prevent the patient from a successful surgery and recovery
  • Women who are nursing or pregnant
  • Patients who smoke
  • Patient's insurance will not cover the cost of surgery.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Danbury Hospital

Danbury, Connecticut, 06810, United States

Location

MeSH Terms

Conditions

Obesity

Interventions

Laparoscopy

Condition Hierarchy (Ancestors)

OverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

EndoscopyDiagnostic Techniques, SurgicalDiagnostic Techniques and ProceduresDiagnosisMinimally Invasive Surgical ProceduresSurgical Procedures, Operative

Study Officials

  • Pierre Saldinger, M.D.

    Danbury Hospital

    STUDY CHAIR
  • Keith Saldinger, M.D.

    Danbury Hospital

    PRINCIPAL INVESTIGATOR
  • Suzanne J House, M.S., Ph.D.

    Danbury Hospital

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Director, Office of Clinical Trials

Study Record Dates

First Submitted

August 9, 2010

First Posted

August 17, 2010

Study Start

March 1, 2010

Primary Completion

July 1, 2014

Study Completion

July 1, 2014

Last Updated

August 22, 2014

Record last verified: 2014-08

Locations